LYMANE Medical
0897.474.385 · rovalta.com · 25/09/2026
LYMANE Medical
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOLYMANE Medical is a Private limited company incorporated in 2008. Its registered office is in Vilvoorde.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0897.474.385
- Incorporation
- 23/04/2008
- Legal form
- Private limited company
- Registered office
- Sint-Annalaan 604
1800 Vilvoorde · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 17 filingsTrend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 110,3 k € | +37.1% | 80,5 k € | -5.1% | 84,8 k € | +23.8% | 68,5 k € | -5.0% | 72,2 k € |
| EBITDA | 109 k € | +36.8% | 79,7 k € | -5.1% | 83,9 k € | +24.2% | 67,6 k € | -5.8% | 71,8 k € |
| Operating result | 106,6 k € | +37.3% | 77,6 k € | -4.2% | 81,1 k € | +24.9% | 64,9 k € | -6.4% | 69,3 k € |
| Net result | 69,6 k € | +35.0% | 51,6 k € | -5.6% | 54,7 k € | +28.1% | 42,7 k € | -11.6% | 48,3 k € |
| Balance sheet | |||||||||
| Equity | 625,7 k € | +12.5% | 556,1 k € | +10.2% | 504,5 k € | +12.1% | 449,9 k € | +10.5% | 407,2 k € |
| Total assets | 655,6 k € | +13.0% | 580 k € | +8.1% | 536,6 k € | +14.5% | 468,8 k € | +11.4% | 421 k € |
| Cash | 42,8 k € | +132% | 18,4 k € | +40564% | 45,3 € | -99.6% | 11,3 k € | +13938% | 80,6 € |
| Debts | 26,1 k € | +9.4% | 23,8 k € | -25.5% | 32 k € | +69.2% | 18,9 k € | +37.1% | 13,8 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/08/2026 | 22/09/2025 | 30/09/2024 | 28/08/2023 | 22/08/2022 | 30/08/2021 |
| General meeting | 30/06/2026 | 26/06/2025 | 29/06/2024 | 15/06/2023 | 16/06/2022 | 22/07/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 17 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 30/06/2026 | 31/08/2026 | Dutch | |
| Micro model | 31/12/2024 | 26/06/2025 | 22/09/2025 | Dutch | |
| Micro model | 31/12/2023 | 29/06/2024 | 30/09/2024 | Dutch | |
| Micro model | 31/12/2022 | 15/06/2023 | 28/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 16/06/2022 | 22/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 22/07/2021 | 30/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 18/06/2020 | 13/08/2020 | Dutch | |
| Micro model | 31/12/2018 | 20/06/2019 | 12/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 21/06/2018 | 14/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 15/06/2017 | 17/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 16/06/2016 | 22/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 18/06/2015 | 25/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 19/06/2014 | 27/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 20/06/2013 | 27/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 21/06/2012 | 17/08/2012 | Dutch | |
| Abridged model | 31/12/2010 | 16/06/2011 | 03/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 17/06/2010 | 30/08/2010 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202569,6 k €↑
- 2024Annual accounts 202451,6 k €↓
- 2023Annual accounts 202354,7 k €↑
- 2023Name changeLYMANE MEDICAL
- 2022Annual accounts 202242,7 k €↓
- 2021Annual accounts 202148,3 k €↓
- 2021Name changeDR. BANOTA LUKUYA LUC
- 2020Annual accounts 202067,5 k €↑
- 2019Annual accounts 201942,6 k €↓
- 2018Annual accounts 201849,6 k €↑
- 2017Annual accounts 201746,8 k €↑
- 2016Annual accounts 201629,7 k €↑
- 2015Annual accounts 201527,1 k €↓
- 2014Annual accounts 201431,6 k €↑
- 2013Annual accounts 201327,5 k €↑
- 2012Annual accounts 201223,8 k €↑
- 2011Annual accounts 201117,5 k €↑
- 2010Annual accounts 20101,7 k €↓
- 2009Annual accounts 20098,3 k €
- 23/04/2008IncorporationPrivate limited company